In 2019, the US spent $3.8 trillion on health care, including an estimated $370 billion on retail prescription drugs alone.1 On average, individuals in the US spend more than $1100 per capita annually out of pocket on health care,2 but this spending is inequitably distributed. Specifically, racial and ethnic minority populations, who disproportionately experience higher prevalence and greater severity of chronic diseases, are more likely to not have sufficient insurance or lack insurance completely. As a result, Black individuals and Hispanic individuals often report the highest rates of cost-related delays in care and lower access to high-quality medication therapy.3
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Essien UR, Dusetzina SB, Gellad WF. A Policy Prescription for Reducing Health Disparities—Achieving Pharmacoequity. JAMA. 2021;326(18):1793–1794. doi:10.1001/jama.2021.17764
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.